Deep learning for liquid biopsy analysis. Making early cancer detection accessible and affordable.
Cancer detected early is often curable. Detected late, it's frequently fatal. The difference between stage 1 and stage 4 is survival.
My PhD research at the Netherlands Cancer Institute focused on identifying cancer signals in cell-free DNA using deep learning. The patterns exist in the blood, invisible to traditional methods, but detectable with the right models at a fraction of the cost.
I'm building a system to make this accessible: liquid biopsy analysis that integrates into routine blood work, catching cancers at stage 1 when survival rates are dramatically higher.
Currently developing the prototype. Consulting on AI systems to fund the R&D.
Building toward liquid biopsy cancer detection while consulting on applied AI.
ML pipelines and complex analysis for research and industry. From messy data to actionable insights.
Autonomous systems that reason, search, and act. RAG, tool use, and multi-agent architectures.
Local AI deployment and infrastructure. Helping you choose between cloud and on-premise.